Recent Quotes (30 days)

You have no recent quotes
chg | %

Aralez Pharmaceuticals Inc  

(Public, TSE:ARZ)   Watch this stock  
Find more results for ARZ
5.00
-0.17 (-3.29%)
Apr 29 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 4.74 - 5.44
52 week 4.50 - 8.45
Open 4.94
Vol / Avg. 12,879.00/15,118.00
Mkt cap 309.62M
P/E     -
Div/yield     -
EPS -1.45
Shares 63.96M
Beta     -
Inst. own     -
Mar 15, 2016
Q4 2015 Aralez Pharmaceuticals Inc Earnings Release
Mar 15, 2016
Q4 2015 Aralez Pharmaceuticals Inc Earnings Call - Webcast
Mar 7, 2016
Aralez Pharmaceuticals Inc at Cowen Health Care Conference
  

Key stats and ratios

Q4 (Dec '15) 2015
Net profit margin -223.38% -176.63%
Operating margin -236.96% -175.15%
EBITD margin - -175.07%
Return on average assets -141.62% -91.36%
Return on average equity -243.91% -122.83%
Employees 105 -
CDP Score - -

Address

151 Steeles Ave E
MILTON, ON L9T 1Y1
Canada
+1-905-8761118 (Phone)

Description

Aralez Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The Company is engaged in acquiring, developing and commercializing products in cardiovascular, pain and other specialty areas. The Company's cardiovascular health products include Bezalip SR, Fibricor, Viskazide, Visken and Yosprala. The Company's pain management products include Cambia, Durela, Fiorinal, Fiorinal C, MT400, Treximet and Vimovo. The Company's other products include Balanse, Balanse Diaflor, Balanse Kids, Collatamp G, Iberogast, Ibsium, MoviPrep, Mutaflor, NeoVisc, Normacol, PegaLAX, Proferrin, Purfem, Resultz, Soriatane and Uracyst. The Company's product, Bezalip SR (bezafibrate), is a pan-peroxisome proliferator-activated receptor (pan-PPAR) activator. The VIMOVO is the brand name for a fixed dose combination of the proton pump inhibitor (PPI) esomeprazole magnesium with the non-steroidal anti-inflammatory drug (NSAID) naproxen in a single tablet.

Officers and directors

Arthur S. Kirsch Independent Chairman of the Board
Age: 63
Andrew I. Koven President, Chief Business Officer
Age: 57
Adrian Adams Chief Executive Officer, Director
Age: 64
Scott J. Charles Chief Financial Officer, Senior Vice President
Age: 41
Jennifer Lou Armstrong Executive Vice President - Human Resources and Administration
Age: 45
Eric L. Trachtenberg Chief Compliance Officer, General Counsel, Corporate Secretary
Age: 42
Mark A. Glickman Chief Commercial Officer
Age: 50
James P. Tursi M.D. Chief Medical Officer
Age: 51
Kenneth B. Lee Jr. Lead Independent Director
Age: 68
Jason M. Aryeh Independent Director
Age: 47